Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian C Miller

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 17, 2025
Structure-guided design and engineering of a biparatopic antibody targeting CCR2 in triple negative breast cancerTimothy S Little, Yuyan Wang, Ameya P Chaudhari, et al.
Nature Immunology|September 19, 2019
PTPN2 regulates the generation of exhausted CD8<sup>+</sup> T cell subpopulations and restrains tumor immunityMartin W LaFleur, Thao H Nguyen, Matthew A Coxe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2024
Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201)Jeffrey L Jensen, Olivia Bobek, Irenaeus C C Chan, et al.
Cell Host & Microbe|November 11, 2008
Autophagosome-independent essential function for the autophagy protein Atg5 in cellular immunity to intracellular pathogensZijiang Zhao, Blima Fux, Megan Goodwin, et al.
Journal for Immunotherapy of Cancer|March 10, 2022
PI3K activation allows immune evasion by promoting an inhibitory myeloid tumor microenvironmentNatalie B Collins, Rose Al Abosy, Brian C Miller, et al.
Cancer Immunology Research|August 26, 2024
Age-Associated Contraction of Tumor-Specific T Cells Impairs Antitumor ImmunityPeter Georgiev, SeongJun Han, Amy Y Huang, et al.
Nature|July 21, 2017
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy targetRobert T Manguso, Hans W Pope, Margaret D Zimmer, et al.
Cell|December 10, 2020
Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor ImmunityAlison E Ringel, Jefte M Drijvers, Gregory J Baker, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 ImmunotherapyMatthew P Zimmerman, Amy C Huang, Emily K Cox, et al.
The Journal of Clinical Investigation|April 23, 2026
T cell receptor signaling induces expression of lysine demethylase KDM6B to maintainTreg homeostasisMinghong He, Beisi Xu, Pria G Bose, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 17, 2025
Structure-guided design and engineering of a biparatopic antibody targeting CCR2 in triple negative breast cancerTimothy S Little, Yuyan Wang, Ameya P Chaudhari, et al.
Nature Immunology|September 19, 2019
PTPN2 regulates the generation of exhausted CD8<sup>+</sup> T cell subpopulations and restrains tumor immunityMartin W LaFleur, Thao H Nguyen, Matthew A Coxe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2024
Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201)Jeffrey L Jensen, Olivia Bobek, Irenaeus C C Chan, et al.
Cell Host & Microbe|November 11, 2008
Autophagosome-independent essential function for the autophagy protein Atg5 in cellular immunity to intracellular pathogensZijiang Zhao, Blima Fux, Megan Goodwin, et al.
Journal for Immunotherapy of Cancer|March 10, 2022
PI3K activation allows immune evasion by promoting an inhibitory myeloid tumor microenvironmentNatalie B Collins, Rose Al Abosy, Brian C Miller, et al.
Cancer Immunology Research|August 26, 2024
Age-Associated Contraction of Tumor-Specific T Cells Impairs Antitumor ImmunityPeter Georgiev, SeongJun Han, Amy Y Huang, et al.
Nature|July 21, 2017
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy targetRobert T Manguso, Hans W Pope, Margaret D Zimmer, et al.
Cell|December 10, 2020
Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor ImmunityAlison E Ringel, Jefte M Drijvers, Gregory J Baker, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 ImmunotherapyMatthew P Zimmerman, Amy C Huang, Emily K Cox, et al.
The Journal of Clinical Investigation|April 23, 2026
T cell receptor signaling induces expression of lysine demethylase KDM6B to maintainTreg homeostasisMinghong He, Beisi Xu, Pria G Bose, et al.
Pageof 4